fluorescein-5-isothiocyanate has been researched along with Shock in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Higashi, T; Ishizuka, T; Kashitani, M; Kobayashi, Y; Matsui, T; Nishii, K; Saitoh, D; Satoh, Y | 1 |
| Bai, XD; Guo, SJ; Hu, S; Hu, XH; Li, ZY; Liu, R; Wang, SM; Zhou, FQ | 1 |
2 other study(ies) available for fluorescein-5-isothiocyanate and Shock
| Article | Year |
|---|---|
Evans Blue and Fluorescein Isothiocyanate-Dextran Double Labeling Reveals Precise Sequence of Vascular Leakage and Glial Responses After Exposure to Mild-Level Blast-Associated Shock Waves.
Topics: Animals; Blood-Brain Barrier; Brain; Brain Concussion; Dextrans; Evans Blue; Fluorescein-5-isothiocyanate; Male; Mice; Shock | 2023 |
Pyruvate in oral rehydration salt improves hemodynamics, vasopermeability and survival after burns in dogs.
Topics: Animals; Bicarbonates; Burns; Capillary Permeability; Disease Models, Animal; Dogs; Fluid Therapy; Fluorescein-5-isothiocyanate; Glucose; Hemodynamics; Lactic Acid; Platelet Activating Factor; Potassium Chloride; Pyruvic Acid; Random Allocation; Shock; Sodium Chloride; Vascular Endothelial Growth Factor A | 2016 |